Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 2
1986 1
2006 1
2008 4
2009 3
2010 2
2012 6
2013 7
2014 4
2015 3
2016 3
2017 7
2018 8
2019 8
2020 6
2021 9
2022 12
2023 14
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Among authors: moran gw. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
Kapizioni C, Desoki R, Lam D, Balendran K, Al-Sulais E, Subramanian S, Rimmer JE, De La Revilla Negro J, Pavey H, Pele L, Brooks J, Moran GW, Irving PM, Limdi JK, Lamb CA; UK IBD BioResource Investigators; Parkes M, Raine T. Kapizioni C, et al. Among authors: moran gw. J Crohns Colitis. 2024 Jun 3;18(6):790-800. doi: 10.1093/ecco-jcc/jjad203. J Crohns Colitis. 2024. PMID: 38041850 Free PMC article.
Systematic review with meta-analysis: Medical therapies for treatment of ulcerative proctitis.
Aruljothy A, Singh S, Narula N, Moran GW, Vuyyuru SK, Hogan M, Zayadi A, MacDonald JK, Caron B, Danese S, Peyrin Biroulet L, Ma C, Jairath V. Aruljothy A, et al. Among authors: moran gw. Aliment Pharmacol Ther. 2023 Oct;58(8):740-762. doi: 10.1111/apt.17666. Epub 2023 Aug 17. Aliment Pharmacol Ther. 2023. PMID: 37589498 Free PMC article. Review.
Tofacitinib in ulcerative colitis.
Archer TP, Moran GW, Ghosh S. Archer TP, et al. Among authors: moran gw. Immunotherapy. 2016 May;8(5):495-502. doi: 10.2217/imt-2015-0031. Immunotherapy. 2016. PMID: 27140405 Review.
Systematic review: Sarcopenia in paediatric inflammatory bowel disease.
Aljilani B, Tsintzas K, Jacques M, Radford S, Moran GW. Aljilani B, et al. Among authors: moran gw. Clin Nutr ESPEN. 2023 Oct;57:647-654. doi: 10.1016/j.clnesp.2023.08.009. Epub 2023 Aug 21. Clin Nutr ESPEN. 2023. PMID: 37739718 Free article. Review.
Evolution of treatment targets in Crohn's disease.
White JR, Jairath V, Moran GW. White JR, et al. Among authors: moran gw. Best Pract Res Clin Gastroenterol. 2019 Feb-Apr;38-39:101599. doi: 10.1016/j.bpg.2019.02.001. Epub 2019 Feb 16. Best Pract Res Clin Gastroenterol. 2019. PMID: 31327410 Review.
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Dickins B, Din S, Emsley R, Foulds GA, Gribben J, Hawkey C, Irving PM, Kazmi M, Lee E, Loban A, Lobo A, Mahida Y, Moran GW, Papaioannou D, Parkes M, Peniket A, Pockley AG, Satsangi J, Subramanian S, Travis S, Turton E, Uttenthal B, Rutella S, Snowden JA. Lindsay JO, et al. Among authors: moran gw. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):333-345. doi: 10.1016/S2468-1253(23)00460-0. Epub 2024 Feb 7. Lancet Gastroenterol Hepatol. 2024. PMID: 38340759 Free article. Clinical Trial.
Ustekinumab: a novel therapeutic option in Crohn's disease.
Simon EG, Samuel S, Ghosh S, Moran GW. Simon EG, et al. Among authors: moran gw. Expert Opin Biol Ther. 2016 Aug;16(8):1065-74. doi: 10.1080/14712598.2016.1205582. Expert Opin Biol Ther. 2016. PMID: 27341173 Review.
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Jairath V, Zou G, Wang Z, Adsul S, Colombel JF, D'Haens GR, Freire M, Moran GW, Peyrin-Biroulet L, Sandborn WJ, Sebastian S, Travis S, Vermeire S, Radulescu G, Sigler J, Hanžel J, Ma C, Sedano R, McFarlane SC, Arya N, Beaton M, Bossuyt P, Danese S, Green D, Harlan W 3rd, Horynski M, Klopocka M, Petroniene R, Silverberg MS, Wolanski L, Feagan BG. Jairath V, et al. Among authors: moran gw. BMJ Open Gastroenterol. 2024 Feb 8;11(1):e001218. doi: 10.1136/bmjgast-2023-001218. BMJ Open Gastroenterol. 2024. PMID: 38336367 Free PMC article.
99 results